icon-folder.gif   Conference Reports for NATAP  
 
  The Liver Meeting
AASLD 2025
Washington, D.C.
November 7-11, 2025
 Back grey_arrow_rt.gif
 
 
 
Two-year Time Course of Biomarker and Imaging Responses in Patients with Well-Compensated MASH Cirrhosis Treated With Resmetirom Two-year Time Course of Biomarker and Imaging Responses in Patients with Well-Compensated MASH Cirrhosis Treated With Resmetirom
 
 
 
AASLD 2025 Nov 7-11 Wash DC

1116251

1116252

1116253

1116254

1116255

1116256

1116257

1116258